SS

Swapnesh Sanjayrao Dhakre

Active Director Director DIN 09176171
DIN 09176171 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Swapnesh Sanjayrao Dhakre

Data last updated:

Swapnesh Sanjayrao Dhakre is a Director at Dakshata Healthcare Private Limited (since 2021). The company operates in Chemicals.

DIN 09176171
Primary Designation Director
Industry Chemicals
First Appointment 17 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dakshata Healthcare Private Limited U24299MH2021PTC360525
Director17 May 20212021Active

Board colleagues of Swapnesh Sanjayrao Dhakre

NameDINCompanyDesignation
Rasika Swapnesh Dhakare09176172Dakshata Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dakshata Healthcare Private Limited
Premium access

Shareholding and investment profile for Swapnesh Sanjayrao Dhakre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapnesh Sanjayrao Dhakre

Swapnesh Sanjayrao Dhakre currently holds 1 directorship: Dakshata Healthcare Private Limited (Director, since 17 May 2021).

Swapnesh Sanjayrao Dhakre was first appointed on 17 May 2021 as Director at Dakshata Healthcare Private Limited.

The current boards of Swapnesh Sanjayrao Dhakre's companies include Rasika Swapnesh Dhakare (Dakshata Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available